Partnership that would prioritise UK could produce 100m doses by year-end if treatment is effective

Research paper published in journal Nature identifies number of alternative treatments

First country to get a vaccine could have an economic as well as a health advantage

Biotech group’s shares have soared this year on hopes drug could be used to treat coronavirus

US-led trial shows positive results in hastening recovery time for coronavirus patients

Investors have bet on Gilead’s remdesivir as solution to coronavirus crisis

Sum far exceeds $8bn fundraising target at upcoming EU-led donors’ conference

Industry highlights bottlenecks in access to materials that are a possible Covid-19 treatment

Pharma and its critics agree government has a big role to play in ensuring fair access to Covid-19 remedies

Federal Trade Commission votes 3-2 to approve tie-up between makers of Botox and Humira

The wide variety of Covid-19 symptoms seen by doctors is confounding the scientific community

Fund managers and energy-hungry tech companies bankroll ‘solar-plus-storage’ projects

Schemes to look at cutting emissions in sectors such as transport in push to meet 2050 ‘net zero’ target

California utility discloses $5bn pre-tax charge tied to claims

The president has turned his populist fire on big business, but is he attacking corporate greed or political opponents?

Group says 230 jobs will be lost at Selby site at it looks to beat 2025 fossil fuel deadline

American producers are coming under pressure on several fronts

Policy reversal follows Cameron vow to rid UK of ‘unsightly’ structures

Demand for classically defensive stocks rises as viral outbreak worsens

As Beijing connects the region, the Philippines weighs ‘shutdown’ risk

Climate campaigners say measures lack ambition to tackle crisis

One of the first large acquisitions to be agreed since coronavirus pandemic rocked global markets

Energy, water and other utility groups keep services going despite lockdowns and cuts

Decline leads to a drop in wholesale prices as businesses close

Loan scheme worth up to £100m a month would allow suppliers to assist struggling customers

First signs of severity of coronavirus pandemic on UK energy sector 

A boom in projects across the Permian Basin comes amid coronavirus fears and a global oil price war 

If lenders maintain support, the company’s balance sheet may not need an urgent fix

Suffolk residents cry foul as French group seeks to continue process despite lockdown  

Potential cost cuts should not be used as justification for a UK telecoms tie-up

Buyers who get cold feet tend to have the advantage but jilted targets can still extract value

Customers and investors may appear immune to staff complaints but regulators have not lost interest

Well-capitalised businesses will have an increased advantage for the next few years

Retail sales rise by 40 per cent in second quarter

Investment group that owns US malls pledges to help groups weather coronavirus crisis

Join our live discussion with buying agent Henry Pryor on Friday May 8 at 12 and 5pm UK time

Trump ally Tom Barrack’s investment group in talks with lenders over hotel and nursing home debt

Epidemiologist Anders Tegnell says other countries could face big ‘second wave’

Investors demanded too high a price to lend to US carrier reeling from coronavirus shutdown

The FT analyses the scale of outbreaks and the number of deaths around the world

Interest rate cuts and massive fiscal stimulus are expected to weigh on the greenback

Eighth consecutive cut could heap fresh pressure on already struggling lira

First-quarter volatility deals $39bn blow to SNB as it steps up fight for Swiss franc

Mike Mackenzie’s daily analysis of what’s moving global markets

Short bets rise to highest level of 2020 over Brexit and Covid-19 concerns

Mike Mackenzie’s daily analysis of what’s moving global markets

‘Cat-and-mouse game’ pitches central bank against market forces

Large foreign financing requirement and small reserves leave Erdogan facing cash crunch

Currency softens beyond key level as investors brace themselves for more interest rate cuts